"Neue Phase der Pandemie" - Experte warnt vor zwei Dingen
Covid19-Sources
Effectiveness of Monovalent mRNA Vaccines Against ...
SARS-CoV-2 und die Laborursprungshypothese - Ist was dran?
Nicht die Impfung, sondern Covid-19 macht Männer unfruchtbar
LangzeitCOVID on Twitter
SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents
Jan Hartmann on Twitter
Lasting Lung Damage Seen in Children and Teens after COVID
Pulmonary Dysfunction after Pediatric COVID-19
Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies
Addiction drug shows promise lifting long COVID brain fog, fatigue
WHO chief scientist sounds alarm on new Covid wave due to XXB variant
Why Experts Are Warning About 'Troublesome' COVID Variants BQ.1 and BQ.1.1
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
Why scientists are keeping an eye on two new Omicron subvariants and what they could mean for Ontario
Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism - Molecular Medicine
Vaccines to treat cancer possible by 2030, say BioNTech founders
RKI - Influenza - Wie hoch ist die Wirksamkeit der Influenza-Impfung?
Age-stratified infection fatality rate of COVID-19 in the non-elderly informed from pre-vaccination national seroprevalence studies
Covid-19 auf den Intensivstationen der München Klinik
WHO chief urges immediate action to tackle ‘devastating’ long Covid
Corona-Pandemie: Lebenserwartung in Teilen Deutschlands stark gesunken
Arthritis urica: Sterblichkeitsrisiko durch COVID-19 ist bei Gicht erhöht, vor allem für Frauen
The Neurobiology of Long COVID
Taxonium
Theo Sanderson on Twitter
As Omicron mutates wildly the virus shows first signs of convergent evolution
Replication of SARS-CoV-2 in adipose tissue determines organ and systemic lipid metabolism in hamsters and humans
Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial